OTCMKTS:CRLBF Cresco Labs Earnings Date & Estimates $0.64 -0.01 (-0.79%) As of 03:59 PM Eastern Cresco Labs is estimated to report earnings on Thursday, November 5, 2026, before market opens. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement Announcement DateNovember 5, 2026TimeBefore Market Opens Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Cresco LabsCresco Labs is expected to post earnings of -$0.02 per share on revenue of $173.66 million. In the same quarter a year earlier Cresco Labs reported -$0.05 per share on revenue of $165.00 million. Cresco Labs last reported on August 6, 2026, posting $0.04 per share and beating the -$0.02 consensus estimate. Cresco Labs has beaten the consensus EPS estimate in 1 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.02Expected Revenue$173.66 millionPrior-Year EPS-$0.05Prior-Year Revenue$165.00 millionExpected Revenue Growth+5.2%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.04 (Beat by +$0.06)Last Quarter Revenue$173.34 millionEPS Beat Rate1 of last 8 quartersPrepare for the Earnings CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Cresco Labs Earnings FAQ When does Cresco Labs report earnings? Cresco Labs (OTCMKTS:CRLBF) is estimated to report earnings on Thursday, November 5, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for Cresco Labs? Analysts expect Cresco Labs to post earnings of -$0.02 per share for the quarter. How much revenue is Cresco Labs expected to report? The consensus revenue estimate for Cresco Labs is $173.66 million for the quarter. Cresco Labs Earnings HeadlinesCresco Labs Announces Filing of Supplement to Management Information Circular for Annual General and Special MeetingOctober 9 at 5:10 PM | financialpost.comFCresco Labs (OTCMKTS:CRLBF) Stock Rating Upgraded by Zacks ResearchOctober 8, 2026 | americanbankingnews.comWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.October 12 at 1:00 AM | Awesomely (Ad)Cresco Labs Announces Filing of Management Information Circular for Annual General and Special MeetingSeptember 24, 2026 | financialpost.comFCresco Labs Announces Filing of Management Information Circular for Annual General and Special MeetingSeptember 24, 2026 | businesswire.comCresco Labs Inc. (CL:CA): Analysts Forecast Big Upside For StockSeptember 21, 2026 | theglobeandmail.comSee More Cresco Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Cresco Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cresco Labs and other key companies, straight to your email. Email Address About Cresco LabsCresco Labs (OTCMKTS:CRLBF) is a vertically integrated cannabis company headquartered in Chicago, Illinois. Founded in 2013, the company cultivates, manufactures and distributes cannabis products for adult-use and medical markets in states where cannabis is legally permitted. The company’s product portfolio includes flower, pre-rolls, vapes, concentrates, edibles and other cannabis products sold under brands such as Cresco, High Supply, Good News, Wonder Wellness, FloraCal, Remedi and Mindy’s Edibles. Cresco Labs also operates Sunnyside dispensaries, which sell cannabis products directly to consumers. Cresco Labs serves multiple U.S. cannabis markets, including Illinois and other states with regulated adult-use or medical programs. Its operations generally span cultivation facilities, processing and manufacturing sites, wholesale distribution and retail dispensaries, allowing the company to participate in several stages of the cannabis supply chain.View Cresco Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 5 Retail Picks to Watch as the Holiday Shopping Season NearsMarketBeat Week in Review – 10/05 - 10/09Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextDelta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsC.H. Robinson Bets Its AI Story on RXO—But the Market Isn't SoldApplied Digital’s Hidden Moat Could Unlock Massive Upside Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
